← All trials
NCT06789783
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2024
- Primary completion
- Sep 30, 2025
- Completion date
- Dec 31, 2026
- First posted
- Jan 23, 2025
- Last posted
- Jan 28, 2025
- Enrollment
- 34
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MilanLead sponsor
- University of MilanOfficial
- University of MilanSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.